TCL Archive EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure. March 2, 2007
TCL Archive Varmus: NCI Faces “Budgetary Disaster;” Flat Funds, Cuts Loom For Most Programs January 14, 2011
TCL Archive European regulators plan more rigorous rules for accelerated approval in cancer. November 11, 2005
TCL Archive Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease December 28, 2012
TCL Archive In Brief: Einstein Center Wins BMS Research Grant; M.D. Anderson Honors Frederick Becker March 26, 1999
TCL Archive In Brief: Diane Fink Moves to ACS California Div.; Preisler Names Director Of Cancer Center In Cincinnati February 10, 1989